Entering text into the input field will update the search result below

Biofrontera trades in green on higher prelim revenue for April

  • Biofrontera (NASDAQ:BFRA) trades 5.9% higher premarket after estimating April product sales revenue to be ~€2.49M compared to €0.49M in same month last year.
  • Prelim product sales revenues in U.S. increased 447% to €1.82M; Germany revenues rose 208% to €0.44K; in rest of Europe, the company product sales surged multiple times to €0.23M from €17K in

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
BFAGY--
Biofrontera AG